Carlsmed, Inc. engages in the development of AI based technology solutions to the medical industry. The company is headquartered in Carlsbad, California and currently employs 127 full-time employees. The company went IPO on 2025-07-23. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights for each surgeon. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.
Mr. Michael Cordonnier is the Chairman of the Board of Carlsmed Inc, joining the firm since 2018.
What is the price performance of CARL stock?
The current price of CARL is $12.15, it has increased 0.33% in the last trading day.
What are the primary business themes or industries for Carlsmed Inc?
Carlsmed Inc belongs to Health Care industry and the sector is Health Care
What is Carlsmed Inc market cap?
Carlsmed Inc's current market cap is $324.7M
Is Carlsmed Inc a buy, sell, or hold?
According to wall street analysts, 7 analysts have made analyst ratings for Carlsmed Inc, including 4 strong buy, 6 buy, 1 hold, 0 sell, and 4 strong sell